Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726308 | SCV000343622 | uncertain significance | not provided | 2016-07-19 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000269889 | SCV000595363 | uncertain significance | not specified | 2016-04-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000726308 | SCV000773189 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000726308 | SCV001896521 | benign | not provided | 2020-03-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000269889 | SCV002755861 | benign | not specified | 2017-07-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000726308 | SCV004010948 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | NEXMIF: BP4, BS2 |